Published date: 17 November 2020
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Biomedical equipment - 38434540
Location of contract
South East
Value of contract
£793,233
Procurement reference
VMIC202021
Published date
17 November 2020
Closing date
12 November 2020
Closing time
9am
Contract start date
27 November 2020
Contract end date
30 November 2021
Contract type
Supply contract
Procedure type
Negotiated procedure without prior publication (above threshold)
The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
VMIC requires the ability to rapidly develop and optimise upstream processes using a state-of-the-art Quality by Design (QBD) approach to ensure robustness as well as rapid development. The ability to execute a Design of Experiments (DoE) approach is integral to the assurance of robustness and furthermore ensures that the processes developed are well away from the edge of failure. VMIC will be a centre of excellence for vaccine development in the UK, and must also have the capability to respond rapidly to pandemic situations, therefore it requires a solution that will allow rapid development of robust processes for clients whilst also allowing a significant reduction in operator-hours and time to create credible processes for anti-pandemic vaccine candidates.
The Sartorius Ambr250 HT system, including installation and 1 year comprehensive service, allows the simultaneous operation of multiple bioreactor vessels working under different operating parameters, with each parameter, addition, feed etc. controlled by robotics in response to a pre-defined operational plan. The time saved using such an automated system is significant and allows for the rapid development of processes in a fraction of the time required using a more traditional approach. It also allows for the scale-down validation of existing processing parameters, thus speeding up the robustness testing and subsequent validation of existing process parameters.
The Ambr 250 HT system is unique in the market place due to the high level of automation and robotics employed to rapidly reduce the time spent in development of mammalian or microbial process, and the high level of automation, microbiological containment, robotics and integrated liquid handling, sampling, and on board sample storage.
VMIC will be a centre of excellence for vaccine development in the UK, and must have the capability to respond rapidly to pandemic situations. The Ambr system will be integral to both these missions because the solution will allow rapid development of robust processes for clients whilst also allowing a significant reduction in operator-hours and time to create credible processes for anti-pandemic vaccine candidates.
More information
Links
Award information
Awarded date
12 November 2020
Contract start date
27 November 2020
Contract end date
30 November 2021
Total value of contract
£793,233
This contract was awarded to 1 supplier.
Sartorius Stedim UK Ltd
Address
Longmead Business Centre, Blenheim Road, Epsom, Surrey, KT19 9QQ
Reference
Companies House number: 06026124
Value of contract
£793,233
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Contact name
Sally Hopkin
Address
John Eccles House, Robert Robinson Avenue
Oxford
OX44GP
England
Website
Share this notice
Closing: 12 November 2020, 9am
All content is available under the
